| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
American pharmaceutical association review of literature on prescription to over-the-counter drug switches
|
Schulke, David G.
|
|
1998
|
20 |
S3 |
p. C124-C133
nvt p.
|
article
|
| 2 |
A process for interpreting data on adverse drug events: determining optimal target levels
|
Rich, Darryl S.
|
|
1998
|
20 |
S3 |
p. C59-C71
nvt p.
|
article
|
| 3 |
Assuring the safe use of medications: the drug approval process and improving treatment decisions
|
Pathak, DevS.
|
|
1998
|
20 |
S3 |
p. C1-C3
nvt p.
|
article
|
| 4 |
Balancing risks versus benefits in drug therapy decisions
|
Lasagna, Louis
|
|
1998
|
20 |
S3 |
p. C72-C79
nvt p.
|
article
|
| 5 |
Developing a uniform reporting system for preventable adverse drug events
|
Cousins, Diane D.
|
|
1998
|
20 |
S3 |
p. C45-C58
nvt p.
|
article
|
| 6 |
Direct-to-consumer advertising: a pharmacy perspective
|
Maine, Lucinda L.
|
|
1998
|
20 |
S3 |
p. C104-C110
nvt p.
|
article
|
| 7 |
Direct-to-consumer promotion: an industry perspective
|
Pines, Wayne L.
|
|
1998
|
20 |
S3 |
p. C96-C103
nvt p.
|
article
|
| 8 |
Evolution of self-care with over-the-counter medications
|
Soller, R.William
|
|
1998
|
20 |
S3 |
p. C134-C140
nvt p.
|
article
|
| 9 |
Limitations and strengths of spontaneous reports data
|
Goldman, Stephen A.
|
|
1998
|
20 |
S3 |
p. C40-C44
nvt p.
|
article
|
| 10 |
Overview of the US Food and Drug Administration's reform legislation
|
Rheinstein, Peter H.
|
|
1998
|
20 |
S3 |
p. C4-C11
nvt p.
|
article
|
| 11 |
Postmarketing drug surveillance: an epidemiologic approach
|
Hennessy, Sean
|
|
1998
|
20 |
S3 |
p. C32-C39
nvt p.
|
article
|
| 12 |
Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety
|
Laughren, Thomas
|
|
1998
|
20 |
S3 |
p. C12-C19
nvt p.
|
article
|
| 13 |
Prescription to over-the-counter switch: a regulatory perspective
|
Juhl, Randy P.
|
|
1998
|
20 |
S3 |
p. C111-C117
nvt p.
|
article
|
| 14 |
Prescription to over-the-counter switches: the physician perspective
|
Byrns, Patricia J.
|
|
1998
|
20 |
S3 |
p. C118-C123
nvt p.
|
article
|
| 15 |
Realizing the promise of the US food and drug administration modernization act
|
Wolgemuth, RichardL.
|
|
1998
|
20 |
S3 |
p. C26-C31
nvt p.
|
article
|
| 16 |
Regulation of prescription drug promotion: direct-to-consumer advertising
|
Baylor-Henry, Minnie
|
|
1998
|
20 |
S3 |
p. C86-C95
nvt p.
|
article
|
| 17 |
Role of evidence-based medicine and clinical practice guidelines in treatment decisions
|
Pearson, Kay C.
|
|
1998
|
20 |
S3 |
p. C80-C85
nvt p.
|
article
|
| 18 |
The US Food and Drug Administration Modernization Act of 1997: impact on consumers
|
Golodner, Linda F.
|
|
1998
|
20 |
S3 |
p. C20-C25
nvt p.
|
article
|
Journal description